Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
AGL Private Credit Income Fund
M&A activity
confidence 85%
filed 2026-05-20
Item 1.01
The filing discloses entry into a second amended and restated LLC agreement for AGL EPCI I involving the admission of new members (AIMCo and additional Vintage Strategies vehicles) and a $54 million transfer of LLC interests. This constitutes a material change in the ownership and capital structure of an unconsolidated entity in which the Company holds interests, meeting the threshold for Item 1.01 material definitive agreement disclosure and representing a material transaction affecting the Company's investment portfolio.
View raw filing on EDGAR →
Lumen Technologies, Inc.
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Lumen announced early results of cash tender offers for approximately $750 million in outstanding debt across multiple subsidiaries and note series. While debt repurchase activity can signal financial management or refinancing strategy, this disclosure does not fit cleanly into the more specific event categories (not M&A, not a covenant breach, not a restatement or going-concern issue). The tender offer itself—a material debt reduction initiative—is a significant corporate action affecting the capital structure and financial obligations of the registrant, warranting classification as a material event outside the standard taxonomy.
View raw filing on EDGAR →
Wendy's Co
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of Robert D. Wright as President and Chief Executive Officer of Wendy's, effective May 21, 2026, and his election to the Board of Directors. While the disclosure also includes compensatory arrangements (base salary of $1 million, performance-based bonus target of 175%, and LTIP awards totaling $5.5 million), the principal disclosed action is the appointment of a new CEO to fill a critical executive role, making exec_appointment the most salient classification. This is material to investors as CEO changes significantly affect corporate strategy and performance expectations.
View raw filing on EDGAR →
Pursuit Attractions & Hospitality, Inc.
M&A activity
confidence 95%
filed 2026-05-20
Item 8.01
The filing discloses an amendment to an Equity Purchase Agreement for the sale of the Company's Flyover flying theater attractions business to Flyover Attractions B.V., extending the outside termination date from May 21, 2026 to July 31, 2026. This constitutes material M&A activity—specifically a disposition of a business unit—that would materially affect a reasonable investor's assessment of the registrant's operations and financial position.
View raw filing on EDGAR →
AKAMAI TECHNOLOGIES INC
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 8.01
Akamai announced the pricing of $3 billion in aggregate principal amount of convertible senior notes ($1.5 billion due 2030 and $1.5 billion due 2032) in a private offering to qualified institutional buyers. This is a material dilutive issuance of convertible debt securities that will likely result in equity dilution upon conversion, consistent with Item 3.02 disclosure requirements and the dilutive_issuance event type.
View raw filing on EDGAR →
APPALACHIAN POWER CO
M&A activity
confidence 75%
filed 2026-05-20
Item 1.01
The filing discloses entry into a material definitive Underwriting Agreement for the issuance of $1.375 billion in Series 2026-A Senior Secured SAC Bonds by Appalachian Power Recovery Funding LLC, with Goldman Sachs, J.P. Morgan, and RBC Capital Markets as underwriters. While this is a debt issuance rather than a traditional M&A transaction, it represents a material financing activity that restructures the capital stack and involves multiple definitive agreements (Underwriting Agreement, Indenture, Intercreditor Agreement, Servicing Agreement, Purchase and Sale Agreement, and Administration Agreement). The magnitude ($1.375B) and complexity of the transaction structure make it material to investors' assessment of the registrant's financial position and capital strategy.
View raw filing on EDGAR →
Oaktree Strategic Credit Fund
Other material
confidence 65%
filed 2026-05-20
Item 7.01
The filing discloses a quarterly shareholder update for Q1 2026 under Item 7.01 (Regulation FD Disclosure), furnished but not filed. While this is a routine quarterly communication to shareholders, it does not fit the earnings_release category (which typically involves formal financial results as a press release exhibit) nor any other specific event type. The update would be material to shareholders assessing fund performance and status, warranting classification as other_material rather than a more specific category.
View raw filing on EDGAR →
ENTRAVISION COMMUNICATIONS CORP
Other material
confidence 72%
filed 2026-05-20
Item 1.02
The filing discloses termination of a Cooperation Agreement between Entravision and the Stockholders (widow of former CEO Walter Ulloa and related trusts) that had governed board nomination rights and stockholder commitments since May 2023. While the termination itself is administrative, the agreement involved material governance arrangements and a significant shareholder relationship tied to the company's former leadership. The event does not fit neatly into the specific taxonomy categories (not an M&A activity, not a covenant breach, not a going-concern issue), making "other_material" the most appropriate classification for this governance-related termination.
View raw filing on EDGAR →
CORVEL CORP
Earnings release
confidence 98%
filed 2026-05-20
Item 2.02
The filing discloses CorVel Corporation's financial results for the three months and fiscal year ended March 31, 2026, via a press release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly and annual financial performance information essential to assessing the registrant's financial condition and results of operations.
View raw filing on EDGAR →
Ally Financial Inc.
Other material
confidence 72%
filed 2026-05-20
Item 5.03
The filing discloses elimination of an entire class of preferred stock (Series B Preferred Stock) via Certificate of Elimination following redemption of all outstanding shares on May 15, 2026. While this is a corporate governance/capital structure event rather than a specific taxonomy category, the redemption and elimination of a preferred stock class materially affects the registrant's capitalization and is disclosed under Item 5.03. This does not fit cleanly into earnings, executive changes, M&A, impairment, or other more specific event types, warranting classification as other_material.
View raw filing on EDGAR →
AVISTA CORP
Other material
confidence 45%
filed 2026-05-20
Item 1.01
The filing references Item 1.01 (Entry into a Material Definitive Agreement) and cross-references Item 2.03 regarding issuance of first mortgage bonds. However, the actual text provided is minimal and does not contain sufficient detail about the nature, terms, or counterparties of the agreement. Without the full Item 1.01 disclosure or Item 2.03 details, the specific event type cannot be reliably determined—it could relate to debt financing, M&A, or another material transaction. The reference to bond issuance suggests debt financing activity, but the incomplete excerpt prevents confident classification into a more specific category.
View raw filing on EDGAR →
AVISTA CORP
M&A activity
confidence 25%
filed 2026-05-20
Item 2.03
This disclosure describes the issuance of $160 million in first mortgage bonds ($90M due 2029 at 4.77%, $70M due 2056 at 6.10%) with an additional $70M expected in August 2026, creating a direct financial obligation under Item 2.03. While the bonds are material debt issuances, the event does not constitute a merger, acquisition, disposition, or change of control—it is a routine debt financing for refinancing and capital expenditures. The most appropriate classification is likely "other_material" rather than "ma_activity," but given the magnitude and direct financial obligation created, this warrants careful consideration of whether it fits the debt covenant or dilutive issuance categories, neither of which apply here.
View raw filing on EDGAR →
AVISTA CORP
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from Avista Corp.'s 2026 Annual Meeting held on May 14, 2026, covering four proposals: election of eleven directors (all approved), ratification of Deloitte & Touche LLP as auditor (approved), advisory vote on executive compensation (approved), and an amendment to reduce shareholder approval thresholds from 80% to majority (not approved). The detailed vote tallies and outcomes directly match Item 5.07 requirements.
View raw filing on EDGAR →
OMNIQ Corp.
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
Item 2.02 disclosure of a press release issued on May 20, 2026 regarding Results of Operations and Financial Condition is a standard earnings release disclosure. The filing explicitly references a press release attached as Exhibit 99.1, which is the typical format for quarterly or annual financial results announcements.
View raw filing on EDGAR →
James Hardie Industries plc
Other material
confidence 65%
filed 2026-05-20
Item 7.01
The filing discloses James Hardie's fiscal year 2026 Irish Statutory Accounts furnished under Item 7.01 (Regulation FD Disclosure). While this represents audited financial statements that would normally constitute an earnings release, the disclosure is explicitly furnished under Regulation FD rather than filed as a formal earnings announcement (Item 2.02), and the prose emphasizes non-filing status and liability disclaimers. This hybrid treatment—statutory accounts disclosed via FD rather than as a traditional earnings release—does not fit cleanly into the earnings_release category and is best classified as other_material given its materiality to investors assessing the registrant's financial position.
View raw filing on EDGAR →
JETBLUE AIRWAYS CORP
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from JetBlue's Annual Meeting of Stockholders held on May 14, 2026. The filing reports voting outcomes on four proposals: election of thirteen directors, advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditor, and approval of an amendment to the 2020 Crewmember Stock Purchase Plan. All results are presented with vote tallies (FOR, AGAINST, ABSTAIN, and broker non-votes), which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
Cenntro Inc.
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 1.01
The filing discloses entry into securities purchase agreements for a private placement of 1,000,000 shares of common stock at $3.93 per share for approximately $3.93 million in gross proceeds. The disclosure explicitly notes compliance with Nasdaq Listing Rule 5635(d) permitting issuance of 20% or more of outstanding common stock without shareholder approval, indicating material dilution. This is a classic dilutive equity issuance requiring Item 1.01 disclosure under Rule 8-K.
View raw filing on EDGAR →
Cenntro Inc.
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 3.02
Item 3.02 discloses an unregistered private placement of common stock exempt under Section 4(a)(2) and Regulation S, with shares subject to transfer restrictions and legend requirements. This is a classic dilutive issuance of equity securities outside registered offerings, material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →
BECTON DICKINSON & CO
M&A activity
confidence 45%
filed 2026-05-20
Item 1.01
This disclosure describes the issuance of €600 million in senior unsecured notes by a BD subsidiary with a full guarantee from the parent company. While Item 1.01 is titled "Entry into a Material Definitive Agreement," the substance here is a debt financing transaction rather than an acquisition, merger, or change of control. The notes are being used to refinance existing debt and fund general corporate purposes. This is more accurately characterized as a material financing event, but the taxonomy lacks a dedicated "debt_issuance" category, making "ma_activity" the closest available fit despite the imperfect match.
View raw filing on EDGAR →
BECTON DICKINSON & CO
Other material
confidence 35%
filed 2026-05-20
Item 2.03
Item 2.03 discloses creation of a direct financial obligation, with content incorporated from Item 1.01. Without access to Item 1.01, the specific nature of the obligation cannot be determined. Item 1.01 typically covers M&A activity, but could also involve debt issuance, lease arrangements, or other financial obligations. Given the materiality threshold of Item 2.03 and the cross-reference structure, this is material but cannot be confidently classified into a more specific category without the referenced Item 1.01 content.
View raw filing on EDGAR →
TRUSTCO BANK CORP N Y
Exec Compensation
confidence 92%
filed 2026-05-20
Item 5.02
The disclosure centers on an amendment to the 2019 Equity Incentive Plan that increases available shares for issuance by 500,000 shares (from 700,000 to 1,200,000), which is a material compensatory arrangement affecting equity grants to officers and directors. This is a classic Item 5.02(e) disclosure of a compensation plan amendment approved by shareholders.
View raw filing on EDGAR →
TRUSTCO BANK CORP N Y
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on May 19, 2026, covering four proposals: election of directors, approval of an amendment to the 2019 Equity Incentive Plan, advisory vote on executive compensation, and ratification of the independent auditor (Crowe LLP). The filing presents detailed voting tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
TRUSTCO BANK CORP N Y
Shareholder vote
confidence 85%
filed 2026-05-20
Item 8.01
The filing discloses materials presented at the 2026 Annual Meeting held on May 19, 2026, filed the next day via 8-K Item 8.01. While the specific vote results are not detailed in the prose itself, the attachment of annual meeting materials to an 8-K within one business day of the meeting strongly indicates disclosure of shareholder vote results, which is a material event affecting investor understanding of governance and corporate direction.
View raw filing on EDGAR →
CareTrust REIT, Inc.
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 8.01
CareTrust REIT completed a registered public offering of 12.5 million shares of common stock at $40.225 per share on May 20, 2026, with an additional 1.875 million shares available under an underwriter option. The offering was conducted through a forward sale structure with Wells Fargo and JPMorgan Chase as forward purchasers. This is a material dilutive equity issuance that increases the company's share count and raises capital, disclosed pursuant to an effective S-3 shelf registration statement.
View raw filing on EDGAR →
Mercedes-Benz Auto Receivables Trust 2026-1
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The filing discloses issuance of $997.87 million in Asset Backed Notes on May 20, 2026, with supporting legal opinions from Sidley Austin LLP. While this represents a material financing event for the trust, it does not fit cleanly into the standard M&A or dilutive issuance categories—it is a securitization/ABS issuance by a special-purpose trust vehicle. The disclosure is routine for ABS trusts but material to investors in the notes themselves.
View raw filing on EDGAR →
BED BATH & BEYOND, INC.
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
The filing discloses two executive appointments: (1) Brian LaRose, the CFO, was appointed principal accounting officer on May 15, 2026, succeeding Leah Putnam; and (2) Tamara Ward was appointed as a director and Chair of the Compensation Committee on the same date. While both are appointments, the principal accounting officer role is a named executive officer position under Item 5.02, making this a material executive appointment. The appointment of a director with committee leadership responsibilities is also material to investors assessing governance and financial oversight.
View raw filing on EDGAR →
MACROGENICS INC
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of MacroGenics' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting outcomes for four proposals: election of four Class I directors (all elected), ratification of Ernst & Young LLP as independent auditor (approved), advisory approval of named executive officer compensation (approved), and amendment to the 2023 Equity Incentive Plan to increase available shares by 1,250,000 (approved). The detailed vote tallies for each proposal are the core content of this Item 5.07 disclosure.
View raw filing on EDGAR →
SKYWORKS SOLUTIONS, INC.
M&A activity
confidence 95%
filed 2026-05-20
Item 8.01
The disclosure announces the commencement of exchange offers and consent solicitations in connection with an anticipated merger transaction in which Qorvo will merge into a Skyworks subsidiary. This constitutes material M&A activity under Item 8.01, as the filing explicitly references "the anticipated transactions pursuant to which Qorvo, Inc. ("Qorvo") will merge with and into a subsidiary of Skyworks" and describes the related debt exchange and consent solicitation mechanics. The merger is a change of control event material to investors.
View raw filing on EDGAR →
Chiron Real Estate Inc.
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
The principal disclosed action is the appointment of Charles Fitzgerald to the Board of Directors, effective May 20, 2026. The filing explicitly states the Board "appointed Charles Fitzgerald to serve as a director of the Company" and details his background, committee assignments, and independence determination. While the section also mentions compensation arrangements and equity plan amendments, the core event is the director appointment.
View raw filing on EDGAR →
Chiron Real Estate Inc.
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 discloses the complete results of the 2026 Annual Meeting of stockholders held on May 20, 2026, including voting outcomes on four proposals: election of six directors, advisory vote on named executive officer compensation, amendment to the 2016 Equity Incentive Plan (extending term and increasing shares by 300,000), and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure required under Item 5.07.
View raw filing on EDGAR →
Chiron Real Estate Inc.
Exec appointment
confidence 92%
filed 2026-05-20
Item 7.01
The filing discloses Mr. Fitzgerald's appointment to the Company's Board of Directors via press release dated May 20, 2026. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is a board appointment, which is material to investors' assessment of corporate governance and leadership composition.
View raw filing on EDGAR →
Fifth District Bancorp, Inc.
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from Fifth District Bancorp's Annual Meeting of Stockholders held on May 18, 2026. The filing reports final voting tallies on director elections (Amie L. Lyons and David C. Nolan) and ratification of EisnerAmper LLP as independent auditor, which are standard matters submitted to stockholder votes at annual meetings. This is a material disclosure as it documents the outcome of corporate governance elections.
View raw filing on EDGAR →
CALIFORNIA WATER SERVICE GROUP
Exec appointment
confidence 85%
filed 2026-05-20
Item 7.01
The filing discloses the promotion of two executives—Tamara S. Johnson to Vice President, California Operations and Gregory D. Shimansky to Vice President, Rates and Regulatory Affairs—effective July 1, 2026. These are material appointments to senior officer positions at a regulated utility company where operational and regulatory leadership are critical to investor assessment.
View raw filing on EDGAR →
Liminatus Pharma, Inc.
M&A activity
confidence 98%
filed 2026-05-20
Item 1.01
The filing discloses entry into a Merger Agreement on May 17, 2026, whereby InnocsAI LLC will merge into a newly-formed subsidiary of Liminatus Pharma, with the Company acquiring a portfolio of oncology-focused biologic and cellular therapy programs (including CAR-T and antibody candidates). The consideration is 1.6 billion shares at $0.20 per share plus contingent value rights tied to future strategic exits. This is a material acquisition transaction requiring stockholder approval and SEC registration, clearly falling under Item 1.01 (Entry into Material Definitive Agreement) and the ma_activity event type.
View raw filing on EDGAR →
REDWOOD TRUST INC
Other material
confidence 75%
filed 2026-05-20
Item 8.01
Redwood Trust entered into an underwriting agreement on May 19, 2026 to sell $125 million in 9.75% senior notes due 2031, with a 30-day over-allotment option for an additional $18.75 million. This is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, but it does not fit neatly into the more specific event categories (it is not M&A, not a dilutive equity issuance, and not a covenant breach or going-concern disclosure). The disclosure is material as it represents a significant financing event.
View raw filing on EDGAR →
SKYWORKS SOLUTIONS, INC.
M&A activity
confidence 98%
filed 2026-05-20
Item 8.01
Skyworks entered into an Agreement and Plan of Merger with Qorvo on October 27, 2025, establishing a two-step merger structure whereby Skyworks' subsidiaries will merge with Qorvo, resulting in Qorvo becoming a wholly owned subsidiary of Skyworks. This is a material acquisition transaction requiring disclosure under Item 1.01 or related M&A provisions, and the filing explicitly states it is being made "in connection with certain transactions related to the Mergers."
View raw filing on EDGAR →
Exyn Technologies, Inc.
Exec Compensation
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses Amendment No. 3 to the Executive Employment Agreement with CEO Brandon Torres Declet, modifying Section 2.6 to establish a new deal completion bonus structure contingent on an IPO, direct listing, or Change in Control. This is a compensatory arrangement modification for a named executive officer, fitting the exec_compensation category. The bonus structure (up to 1.5% of net proceeds or $225,000 minimum) is material to investor assessment of executive incentives and potential dilution in a liquidity event.
View raw filing on EDGAR →
Lument Finance Trust, Inc.
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
The filing discloses quarterly financial results for the period ended March 31, 2026 through a press release and supplemental financial information attached as exhibits. This is a standard earnings release disclosure under Item 2.02, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →
GOLUB CAPITAL BDC, Inc.
M&A activity
confidence 75%
filed 2026-05-20
Item 1.01
The Company entered into an underwriting agreement for the issuance and sale of $500 million in 6.250% Notes due 2031. While this is a debt offering rather than a traditional M&A transaction, Item 1.01 covers "entry into a material definitive agreement," and a $500 million debt issuance is material to the registrant's capital structure and financing activities. The ma_activity classification best captures material financing transactions, though this could also be characterized as "other_material" if debt offerings are not considered within the scope of ma_activity.
View raw filing on EDGAR →
ProMIS Neurosciences Inc.
Exec Compensation
confidence 92%
filed 2026-05-20
Item 5.02
The disclosure centers on stockholder approval of an amendment to the 2025 Stock Option and Incentive Plan that increases the share pool available for issuance by 900,000 Common Shares. This is a compensatory arrangement amendment affecting equity grants to officers and directors, which falls squarely within exec_compensation. The materiality is supported by the substantial increase in authorized shares for equity compensation purposes.
View raw filing on EDGAR →
ProMIS Neurosciences Inc.
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from ProMIS Neurosciences' Annual Meeting held on May 20, 2026, covering three proposals: election of seven directors, ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2025 Stock Option and Incentive Plan. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 disclosure and constitutes material information affecting governance and capital structure.
View raw filing on EDGAR →
NANOVIRICIDES, INC.
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 1.01
NanoViricides entered into a Securities Purchase Agreement on May 15, 2026, for a registered direct offering of 1,133,334 shares of common stock at $1.50 per share, pre-funded warrants, and common warrants, generating approximately $2.0 million in gross proceeds. This is a material equity issuance that dilutes existing shareholders and raises capital through the sale of registered securities, fitting the dilutive_issuance classification.
View raw filing on EDGAR →
NANOVIRICIDES, INC.
Dilutive issuance
confidence 85%
filed 2026-05-20
Item 8.01
The filing discloses an "Offering" announced on May 15, 2026 and closed on May 18, 2026, with press releases attached as exhibits. While the specific terms are not detailed in this Item 8.01 excerpt, the structure and timing of dual announcements (announcement and closing) is consistent with a securities offering. For a small-cap company like Nanoviricides, an offering disclosed via 8-K Item 8.01 typically represents a dilutive equity issuance or capital raise that would be material to investors.
View raw filing on EDGAR →
RLI CORP
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from RLI Corp's May 14, 2026 annual meeting under Item 5.07. The filing reports voting outcomes on three proposals: (1) election of ten directors to one-year terms with detailed vote tallies for each nominee, (2) non-binding advisory approval of named executive officer compensation, and (3) ratification of Deloitte & Touche LLP as independent auditor. The tabular presentation of "For," "Against," "Abstentions," and "Broker Non-Votes" is the standard format for shareholder vote disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →
Senseonics Holdings, Inc.
Other material
confidence 65%
filed 2026-05-20
Item 5.03
The filing discloses a stockholder-approved amendment to the Certificate of Incorporation increasing authorized common shares from 70 million to 140 million, effective May 20, 2026. While this is a structural corporate action that could signal intent to issue additional equity (potentially dilutive), the disclosure itself is a routine charter amendment rather than a specific equity issuance, going-concern warning, or other more defined event type. The materiality lies in the potential for future dilution and the company's capital structure flexibility, making it material to investors but not fitting neatly into the more specific taxonomy categories.
View raw filing on EDGAR →
Senseonics Holdings, Inc.
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 discloses the results of an Annual Meeting of stockholders held on May 20, 2026, covering six proposals: election of three directors (Goodnow, Kaufman, Larkin), advisory vote on named executive officer compensation, frequency of advisory compensation votes, ratification of KPMG LLP as auditor, approval of an amendment to increase authorized common shares from 70 million to 140 million, and approval of the 2026 Equity Incentive Plan. All proposals passed. The disclosure includes vote tallies, broker non-votes, and confirmation that the certificate amendment was filed with Delaware. This is a classic shareholder vote results disclosure material to investors assessing governance and capital structure changes.
View raw filing on EDGAR →
GILEAD SCIENCES, INC.
Other material
confidence 75%
filed 2026-05-20
Item 1.01
Gilead entered into an Eleventh Supplemental Indenture on May 20, 2026, governing the issuance of $3 billion in aggregate principal amount of senior notes across four series (2028, 2029, 2031, and 2034 notes) with interest rates ranging from 4.250% to 4.900%. While this is a material debt issuance disclosed under Item 1.01 (Entry into a Material Definitive Agreement), it does not fit cleanly into the M&A activity category—it is a financing transaction rather than an acquisition, disposition, or change of control. The company intends to use net proceeds for general corporate purposes including potential acquisitions and strategic transactions, but the primary disclosed event is the debt financing itself.
View raw filing on EDGAR →
GILEAD SCIENCES, INC.
Other material
confidence 45%
filed 2026-05-20
Item 2.03
Item 2.03 discloses creation of a direct financial obligation or off-balance sheet arrangement, but the actual substance is incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific event type cannot be determined with confidence. Item 1.01 typically covers material agreements (M&A, debt issuance, or other transactions), so this could be ma_activity, covenant_breach, or another material event. Given the ambiguity and the incorporation-by-reference structure, other_material is the most defensible classification pending review of Item 1.01.
View raw filing on EDGAR →
GILEAD SCIENCES, INC.
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The filing discloses entry into an underwriting agreement for issuance and sale of notes by Gilead Sciences on May 14, 2026, with major underwriters (Barclays, BofA, Citigroup). While this represents a material debt or equity issuance, the Item 8.01 disclosure is sparse and does not specify the security type, amount, or terms. This appears to be a debt offering (referenced as "Notes") but lacks sufficient detail to confirm it as a dilutive equity issuance; it is classified as other_material given the material financing activity disclosed but ambiguity about the precise instrument and its dilutive impact.
View raw filing on EDGAR →
Annovis Bio, Inc.
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 1.01
Annovis Bio entered into an Underwriting Agreement on May 20, 2026 to issue 7,895,000 shares of common stock and 7,105,500 warrants in a public offering expected to raise approximately $15 million in gross proceeds. This is a material dilutive equity issuance disclosed under Item 1.01, with the company planning to use net proceeds for clinical development and working capital—a typical capital raise by a biotech company.
View raw filing on EDGAR →